Back to search

Peptide record

TPDB16853

Antibacterial Antifungal Hemolysis Toxicity standard
10 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB16853
Antibacterial Antifungal Hemolysis Toxicity
Anti-infective peptides Toxicity and safety peptides
dbAMP Peptipedia CAFPdb PD_Hemolysis
standard
No
A 10-aa standard natural multi-activity (Antibacterial, Antifungal, Hemolysis, and other sources) peptide sequence curated from dbAMP, Peptipedia, CAFPdb, and other sources, with an available 3D structural model.
Sequence
GLLKIIKKLL
Physicochemical Analysis
C56H107N13O11
ARNDCEQHMFPSTWYV
L
1138.55
10.84
3
0
6
+3
0.12
1.210
234.00
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
2
I
4
L
3
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 2 L: 4 K: 3 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
10
C56H107N13O11
1138.55
10.84
+3
0.12
1.210
Evidence Records 7 records
Evidence 1 Activity

Activity

15% Hemolysis
Toxicity
100 µg/mL
Hemolytic Cytotoxic
15% Hemolysis | 100 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Novel anoplin-based (lipo)-peptide models show potent antimicrobial activity. | J Pept Sci | 2021
Evidence 2 Activity

Activity

25% Hemolysis
Toxicity
200 µg/mL
Hemolytic Cytotoxic
25% Hemolysis | 200 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Novel anoplin-based (lipo)-peptide models show potent antimicrobial activity. | J Pept Sci | 2021
Evidence 3 Activity

Activity

45% Hemolysis
Toxicity
100 µg/mL
Hemolytic Cytotoxic
45% Hemolysis | 100 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Novel anoplin-based (lipo)-peptide models show potent antimicrobial activity. | J Pept Sci | 2021
Evidence 4 Activity

Activity

80% Hemolysis
Toxicity
100 µg/mL
Hemolytic Cytotoxic
80% Hemolysis | 100 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Novel anoplin-based (lipo)-peptide models show potent antimicrobial activity. | J Pept Sci | 2021
Evidence 5 Activity

Activity

95% Hemolysis
Toxicity
200 µg/mL
Hemolytic Cytotoxic
95% Hemolysis | 200 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Novel anoplin-based (lipo)-peptide models show potent antimicrobial activity. | J Pept Sci | 2021
Evidence 6 Activity

Activity

50% Hemolysis
Toxicity
44.6 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | 44.6 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Novel anoplin-based (lipo)-peptide models show potent antimicrobial activity. | J Pept Sci | 2021
Evidence 7 Hemolysis

Source & Reference

PD_Hemolysis
PD_Hemolysis